A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes
Sponsor: City of Hope Medical Center
New Haven, CT · +10 more sites
13 recruiting type 2 diabetes studies with a site in New Haven, CT.
Sponsor: City of Hope Medical Center
New Haven, CT · +10 more sites
Sponsor: Hoffmann-La Roche
New Haven, CT · +43 more sites
Sponsor: AstraZeneca
New Haven, CT · +55 more sites
Sponsor: Yale University
New Haven, CT
Sponsor: Medtronic MiniMed, Inc.
New Haven, CT · +17 more sites
Sponsor: Eli Lilly and Company
Bridgeport, CT · New Haven, CT · Waterbury, CT · +56 more sites
Sponsor: Eli Lilly and Company
New Haven, CT · +40 more sites
Sponsor: Insulet Corporation
New Haven, CT · +10 more sites
Sponsor: Yale University
New Haven, CT
Sponsor: Sanofi
New Haven, CT · +36 more sites
Sponsor: Yale University
New Haven, CT
Sponsor: Yale University
New Haven, CT
Sponsor: Yale University
New Haven, CT
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.